Clinical Trials Browser

Phase 1/2 × Recurrence × Tretinoin × Clear all

NCT02717884 2018-10-18

TRANSATRA

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute